This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Tick-borne encephalitis vaccination

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

tick-borne encephalitis vaccination

One licensed vaccine (Tico-Vac) is available currently

  • produced from virus grown in chick fibroblasts and then inactivated by formaldehyde; it is supplied as a suspension of 0.5ml for injection in a pre-filled syringe
  • vaccine contains the Neudorfl virus strain, has been shown to be effective against the European subtype, and is probably effective against the more aggressive Far Eastern subtype of TBE
  • vaccine contains aluminium hydroxide and trace quantities of neomycin and gentamicin
  • inactivated, does not contain live organisms and cannot cause the disease against which it protects

Indications:

  • TBE vaccine is used for the protection of individuals at high risk of exposure to the virus through travel or employment
  • risk areas are Eastern Europe, former USSR and forested regions of Austria, Germany, the Balkans and Scandanavia
  • for longterm residents, foresters, scouts and ramblers

Precautions

  • there are no direct evidence associated with vaccinating pregnant women or those who are breast-feeding, with inactivated virus or bacterial vaccines or toxoids

Contraindications:

  • the vaccine should not be given to those who have had:
  • a confirmed anaphylactic reaction to a previous dose of TBE vaccine
  • a confirmed anaphylactic reaction to one of the vaccine components
  • a confirmed anaphylactic reaction to egg ingestion

Adverse Reactions:

  • reported reactions to TBE vaccines are rare
  • local reactions such as swelling, pain and redness at the injection site may occur
  • pyrexia, particularly after the first dose can occur in children and adults, usually occurring within 12 hours of immunisation and settling within 24–48 hours
  • febrile convulsions have rarely occurred, and antipyretic treatment and cooling should be initiated in good time

Check uptodate details in the The Green Book before prescribing/administering a TBE vaccination.

Check the Summary of Product Characteristics (SPC) before prescribing/administering a vaccine.

Reference:

  • (1) Immunisation Against Infectious Disease - "The Green Book".Chapter 31 Tick-borne (April 2019)

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.